The outcome of macroprolactinomas resistant to dopamine agonists
Aim: The present study aims to assess the final outcome after combined therapeutic approaches in patients with macroprolactinoinas resistant to dopamine agonists (DA). Patients: Records of patients with macroprolactinoma hospitalized in the Institute of Endocrinology, Bucharest, between 1978-2005, w...
Auteurs principaux: | Coculescu, M, Anghel, R, Trifanescu, R, Voicu, D, Karavitaki, N, Wass, J |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2005
|
Documents similaires
-
Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.
par: Karavitaki, N, et autres
Publié: (2010) -
Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
par: Barber, T, et autres
Publié: (2011) -
Macroprolactinoma resistente aos agonistas dopaminérgicos: relato de caso Macroprolactinoma resistant to dopamine agonists: a case report
par: Rosana Maria dos Reis, et autres
Publié: (2004-09-01) -
Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature
par: Eng-Loon Tng, et autres
Publié: (2023-03-01) -
Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
par: Karavitaki, N, et autres
Publié: (2013)